UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040196
Receipt number R000045834
Scientific Title Utility of the earliest pulmonary vein potential-guided cryoballoon ablation for atrial fibrillation in a multicenter randomized study
Date of disclosure of the study information 2020/07/01
Last modified on 2024/04/22 16:54:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Utility of the earliest pulmonary vein potential-guided cryoballoon ablation for atrial fibrillation in a multicenter randomized study

Acronym

Utility of the earliest pulmonary vein potential-guided cryoballoon ablation for atrial fibrillation in a multicenter randomized study

Scientific Title

Utility of the earliest pulmonary vein potential-guided cryoballoon ablation for atrial fibrillation in a multicenter randomized study

Scientific Title:Acronym

Utility of the earliest pulmonary vein potential-guided cryoballoon ablation for atrial fibrillation in a multicenter randomized study

Region

Japan


Condition

Condition

Paroxysmal atrial fibrillation

Classification by specialty

Cardiology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate an utility of the earliest pulmonary vein potential-guided cryoballoon ablation for atrial fibrillation

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Recurrence at 12 months after the ablation

Key secondary outcomes

Time to isolation of pulmonary vein potential, procedure time, cryoballoon ablation time, early recurrence...etc.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation


Institution consideration

Institution is considered as a block.

Blocking

YES

Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Pulmonary vein potential-guided cryoballoon ablation

Interventions/Control_2

Control group (conventional cryoballoon ablation)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with paroxysmal atrial fibrillation who are scheduled for cryoballoon ablation

Key exclusion criteria

-Persistent atrial fibrillation
-Impaired renal function/hemodialysis
-Common pulmonary vein anatomy

Target sample size

124


Research contact person

Name of lead principal investigator

1st name Toyoaki
Middle name
Last name Murohara

Organization

Nagoya University Graduate School of Medicine

Division name

Department of Cardiology

Zip code

466-8550

Address

65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8550, Japan.

TEL

81-52-744-2147

Email

murohara@med.nagoya-u.ac.jp.


Public contact

Name of contact person

1st name Satoshi
Middle name
Last name Yanagisawa

Organization

Nagoya University Graduate School of Medicine

Division name

Department of Advanced Cardiovascular Therapeutics

Zip code

466-8550

Address

65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8550, Japan.

TEL

81-52-744-2147

Homepage URL


Email

yanagisawa-sato@med.nagoya-u.ac.jp


Sponsor or person

Institute

Nagoya University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagoya University Graduate School of Medicine Institutional Review Board

Address

65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8550, Japan.

Tel

81-52-744-2942

Email

camcr@med.nagoya-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

市立四日市病院(三重県)、安城更生病院(愛知県)、名古屋市立大学病院(愛知県)、トヨタ記念病院(愛知県)、小牧市民病院(愛知県)


Other administrative information

Date of disclosure of the study information

2020 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

124

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2020 Year 04 Month 18 Day

Date of IRB

2020 Year 09 Month 09 Day

Anticipated trial start date

2020 Year 09 Month 09 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information


Management information

Registered date

2020 Year 04 Month 19 Day

Last modified on

2024 Year 04 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045834


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name